Hank Kung, PhD

Dr. Kung's research group is interested in development of selective radiotracers for in vitro and in vivo imaging studies of CNS receptors and tumor metabolism. The development of new tracers involve multidisciplinary efforts including: synthesis of new ligands, evaluation of structure-activity relationship, radiochemistry of Tc-99m and I-123, C-11 and F-18, and in vitro and in vivo studies of binding affinity and selectivity in cloned cell membrane as well as tissue preparations.